Is a complete FRA/2AB research report available?

No complete published report is available for fra/2AB (FRA/2AB) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/2AB (FRA/2AB)

Frankfurt Stock Exchange: FRA/2AB · EUR

€0.47

-0.00 (-0.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/2AB analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	20.6M
Net income (ttm)	-45.4M
EPS (ttm)	-€1.12
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -45.4M
EPS (ttm): -€1.12
Market cap: 20.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All FRA/2AB indicators

Market & fundamental data

Available fields

139

Groups with data

Currency

USD

Showing 139 of 139 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	14
Employees Change	-25%
Employees Change Percent	-19.23
Enterprise value	EUR -27.5M
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-31
Market cap	EUR 20.6M
Price	EUR 0.47
Price currency	EUR
Sic	2836
Symbol	fra/2AB
Website	https://www.barinthusbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-220.32%
FCF yield	-153.62%
P/B ratio	0.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -291,413
Net Income	EUR -45.4M
Profit Per Employee	EUR -3.2M
ROA	-23.21
Roa5y	-16.05
ROCE	-54.24
ROE	-57.49
Roe5y	-35.32
ROIC	-26.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-67.83%
Cagr3y	-38.69%
Cagr5y	-48.28%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 79.9M
Cash	EUR 57.1M
Current Assets	EUR 63.1M
Current Liabilities	EUR 10.4M
Debt	EUR 9.5M
Debt Equity	EUR 0.17
Debt FCF	EUR -0.3
Equity	EUR 57.7M
Interest Coverage	-852.3
Liabilities	EUR 22.3M
Long Term Assets	EUR 16.8M
Long Term Liabilities	EUR 11.8M
Net Cash	EUR 47.6M
Net Cash By Market Cap	EUR 231
Net Cash Growth	-37.1%
Net Debt Equity	EUR -0.83
Tangible Book Value	EUR 45.7M
Tangible Book Value Per Share	EUR 1.12

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.05
Net Working Capital	EUR -2.8M
Quick ratio	5.6
Working Capital	EUR 52.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.4%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-67.81%
200-day SMA	0.6
3Y total return	-76.96%
50-day SMA	0.54
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.3%
All Time High	14.5
All Time High Change	-96.76%
All Time High Date	2021-05-17
All Time Low	0.45
All Time Low Change	5.38%
All Time Low Date	2026-04-02
ATR	0.02
Ch YTD	-16.07
High	0.47
High52	1.3
High52 Date	2025-10-08
High52ch	-64.15%
Low	0.47
Low52	0.45
Low52 Date	2026-04-02
Low52ch	4.48%
Ma50ch	-13.59%
Price vs 200-day SMA	-21.81%
RSI	37.28
RSI Monthly	34.86
RSI Weekly	39.81
Sharpe ratio	-0.75x
Sortino ratio	-1.01
Total Return	-2.4%
Tr YTD	-16.07
Tr1m	-21.01%
Tr1w	-6%
Tr3m	-8.74%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -37.7M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,257,502%
Shares Insiders	11.74%
Shares Institutions	31.12%
Shares Qo Q	0.03%
Shares Yo Y	2.4%
Short Ratio	0.4

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -32.1M
Adjusted OCF	-32,089,233
Average Volume	0x
Bv Per Share	1.41
CAPEX	EUR -27,754
Ch1m	-21.01
Ch1w	-6
Ch1y	-67.81
Ch3m	-8.74
Ch3y	-76.96
Ch5y	-96.3
Ch6m	-19.66
Change	-0.85%
Change From Open	0
Close	0.47
Days Gap	-0.85
Depreciation Amortization	1,620,455.2
Earnings Date	2026-08-06
EBIT	EUR -37.7M
EBITDA	EUR -36.1M
EPS	EUR -1.12
F Score	1
FCF	EUR -31.6M
FCF EV Yield	114.89x
Fiscal Year End	December
Founded	2,016
Income Tax	EUR -146,574
Investing CF	412,835
Is Primary Listing	0
Last Report Date	2026-03-31
Ma150	0.53
Ma150ch	-11.92%
Ma20	0.51
Ma20ch	-8.49%
Net CF	-28,959,147
Next Earnings Date	2026-08-06
Open	0.47
Ppne	4,252,067.5
Price Date	2026-07-30
Ptbv Ratio	0.45
Share Based Comp	482,219
Tr6m	-19.66%
Volume	0

FRA/2AB (FRA/2AB)

Coverage state: Market snapshot only — no published research

Generate the first FRA/2AB analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/2AB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/2AB indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/2AB

Frequently asked questions